15 results on '"AGABITI‐ROSEI, E."'
Search Results
2. Lack of Effect of Short-term Lisinopril Administration on Left Ventricular Filling Dynamics in Hypertensive Patients with Diastolic Dysfunction
- Author
-
Cuspidi, C., primary, Lonati, L., additional, Sampieri, L., additional, Leonetti, G., additional, Muiesan, M. L., additional, Agabiti-rosei, E., additional, and Zanchetti, A., additional
- Published
- 1997
- Full Text
- View/download PDF
3. Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets
- Author
-
Krzysztof Narkiewicz, Josep Redon, Giuseppe Mancia, Aud Stenehjem, Michel Burnier, Ingrid Os, Enrico Agabiti Rosei, Sverre E. Kjeldsen, Philippe van de Borne, Kjeldsen, S, Stenehjem, A, Os, I, Van de Borne, P, Burnier, M, Narkiewicz, K, Redon, J, Agabiti Rosei, E, and Mancia, G
- Subjects
medicine.medical_specialty ,Blood Pressure ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Frail elderly ,030212 general & internal medicine ,Intensive care medicine ,Blood pressure-lowering treatment ,Aged ,Aged, 80 and over ,octogenarian ,business.industry ,General Medicine ,blood pressure target ,medicine.disease ,Comorbidity ,elderly patient ,Europe ,Blood pressure ,European Society of Hypertension ,Hypertension ,Isolated systolic hypertension ,Treatment decision making ,Cardiology and Cardiovascular Medicine ,business - Abstract
The European Society of Hypertension recommend the following main rules for treatment of hypertension in elderly and octogenarians: 1) In elderly hypertensives with SBP ≥ 160 mmHg there is solid evidence to recommend reducing SBP to between 140 mmHg and 150 mmHg. 2) In fit elderly patients less than 80 years old treatment may be considered at SBP ≥ 140 mmHg with a target SBP
- Published
- 2016
4. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.
- Author
-
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement D, Coca A, De Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E, Tsioufis K, Aboyans V, and Desormais I
- Subjects
- Advisory Committees, Europe, Female, Humans, Hypertension epidemiology, Hypertension physiopathology, Male, Societies, Medical, Hypertension diagnosis, Hypertension therapy
- Abstract
These practice guidelines on the management of arterial hypertension are a concise summary of the more extensive ones prepared by the Task Force jointly appointed by the European Society of Hypertension and the European Society of Cardiology. These guidelines have been prepared on the basis of the best available evidence on all issues deserving recommendations; their role must be educational and not prescriptive or coercive for the management of individual subjects who may differ widely in their personal, medical and cultural characteristics. The members of the Task Force have participated independently in the preparation of these guidelines, drawing on their academic and clinical experience and by objective examination and interpretation of all available literature. A disclosure of their potential conflict of interest is reported on the websites of the ESH and the ESC.
- Published
- 2018
- Full Text
- View/download PDF
5. Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans.
- Author
-
De Ciuceis C, Agabiti-Rosei C, Rossini C, Airò P, Scarsi M, Tincani A, Tiberio GAM, Piantoni S, Porteri E, Solaini L, Duse S, Semeraro F, Petroboni B, Mori L, Castellano M, Gavazzi A, Agabiti-Rosei E, and Rizzoni D
- Subjects
- Female, Humans, Male, Middle Aged, CD4-Positive T-Lymphocytes metabolism, Oxidative Stress physiology
- Abstract
Background and Objective: Different components of the immune system, including innate and adaptive immunity (T effector lymphocytes and T regulatory lymphocytes - TREGs) may be involved in the development of hypertension, vascular injury and inflammation. However, no data are presently available in humans about possible relationships between T-lymphocyte subtypes and microvascular oxidative stress. Our objective was to investigate possible relationships between T-lymphocyte subtypes and systemic and microvascular oxidative stress in a population of normotensive subjects and hypertensive patients., Patients and Methods: In the present study we enrolled 24 normotensive subjects and 12 hypertensive patients undergoing an elective surgical intervention. No sign of local or systemic inflammation was present. All patients underwent a biopsy of subcutaneous fat during surgery. A peripheral blood sample was obtained before surgery for assessment of T lymphocyte subpopulations by flow cytometry and circulating indices of oxidative stress., Results: A significant direct correlation was observed between Th1 lymphocytes and reactive oxygen species (ROS) production (mainly in microvessels). Additionally, significant inverse correlations were observed between ROS and total TREGs, or TREGs subtypes. Significant correlations were detected between circulating indices of oxidative stress/inflammation and indices of microvascular morphology/Th1 and Th17 lymphocytes. In addition, a significant inverse correlation was detected between TREGs in subcutaneous small vessels and C reactive protein., Conclusions: Our data suggest that TREG lymphocytes may be protective against microvascular damage, probably because of their anti-oxidant properties, while Th1-Th17 lymphocytes seem to exert an opposite effect, confirming an involvement of adaptive immune system in microvascular damage.
- Published
- 2017
- Full Text
- View/download PDF
6. Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets.
- Author
-
Kjeldsen SE, Stenehjem A, Os I, Van de Borne P, Burnier M, Narkiewicz K, Redon J, Agabiti Rosei E, and Mancia G
- Subjects
- Aged, Aged, 80 and over, Europe, Humans, Hypertension epidemiology, Blood Pressure, Hypertension therapy
- Abstract
The European Society of Hypertension recommend the following main rules for treatment of hypertension in elderly and octogenarians: 1) In elderly hypertensives with SBP ≥ 160 mmHg there is solid evidence to recommend reducing SBP to between 140 mmHg and 150 mmHg. 2) In fit elderly patients less than 80 years old treatment may be considered at SBP ≥ 140 mmHg with a target SBP < 140 mmHg if treatment is well tolerated. 3) In fit individuals older than 80 years with an initial SBP ≥ 160 mmHg it is recommended to reduce SBP to between 150 mmHg and 140 mmHg. 4) In frail elderly patients, it is recommended to base treatment decisions on comorbidity and carefully monitor the effects of treatment. 5) Continuation of well-tolerated antihypertensive treatment should be considered when a treated individual becomes octogenarian. 6) All hypertensive agents are recommended and can be used in the elderly, although diuretics and calcium antagonists may be preferred in isolated systolic hypertension.
- Published
- 2016
- Full Text
- View/download PDF
7. Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension.
- Author
-
De Ciuceis C, Rossini C, Tincani A, Airò P, Scarsi M, Agabiti-Rosei C, Ruggeri G, Caimi L, Ricotta D, Agabiti-Rosei E, and Rizzoni D
- Subjects
- Essential Hypertension, Female, Humans, Hypertension physiopathology, Inflammation, Male, Middle Aged, Risk Factors, Antihypertensive Agents adverse effects, Dihydropyridines adverse effects, Endothelial Progenitor Cells metabolism, Hypertension diet therapy
- Abstract
Background: It has been demonstrated that circulating endothelial progenitor cells (EPCs) number reflects the endogenous vascular repair ability, with the EPCs pool declining in presence of cardiovascular risk factors. Several drugs, including dihydropyridine calcium channel blockers, have been reported to elicit antioxidant and anti-inflammatory properties, as well as to improve vascular remodeling and dysfunction. However, no data are available about the effects of lercanidipine on EPCs. The aim of the present study was therefore to investigate the effects of short-term treatment with lercanidipine on circulating EPCs, as well as on indices of inflammation and oxidative stress., Patients and Methods: Twenty essential hypertensive patients were included in the study and treated for 4 weeks with lercanidipine 20 mg per day orally. Investigations were performed in basal condition, after appropriate wash out of previous treatments, and after 4 weeks of lercanidipine treatment. Inflammatory and oxidative stress markers were assessed by ELISA technique. Lin-/7AAD-/CD34+/CD133+/VEGFR-2 + and Lin-/7AAD-/CD34+/VEGFR-2 + cells were identified by flow cytometry and considered as EPCs. EPCs cells were expressed as number of cells per million Lin-mononuclear cells., Results: Circulating EPCs were significantly increased after lercanidipine treatment (CD34+/CD133+/VEGFR-2 + cells: 78.3 ± 64.5 vs 46.6 ± 32.8; CD34+/VEGFR-2+: 87996 ± 165116 vs 1026 ± 1559, respectively, p < 0.05). A modest reduction in circulating indices of inflammation was also observed., Conclusions: In conclusion, lercanidipine is able to increase the number of circulating EPCs, possibly through a reduction of low-grade inflammation.
- Published
- 2016
- Full Text
- View/download PDF
8. Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study.
- Author
-
De Ciuceis C, Flati V, Rossini C, Rufo A, Porteri E, Di Gregorio J, Petroboni B, La Boria E, Donini C, Pasini E, Agabiti Rosei E, and Rizzoni D
- Subjects
- Adult, Aged, Angiotensin-Converting Enzyme Inhibitors pharmacology, Antihypertensive Agents pharmacology, Calcium Channel Blockers pharmacology, Calcium Channel Blockers therapeutic use, Dihydropyridines pharmacology, Drug Combinations, Enalapril pharmacology, Essential Hypertension, Female, Glucose Transporter Type 4 metabolism, Humans, Hypertension metabolism, Lymphocytes drug effects, Lymphocytes metabolism, Male, Middle Aged, Monocytes drug effects, Monocytes metabolism, Nifedipine pharmacology, Pilot Projects, Signal Transduction drug effects, TOR Serine-Threonine Kinases metabolism, Angiotensin-Converting Enzyme Inhibitors therapeutic use, Antihypertensive Agents therapeutic use, Dihydropyridines therapeutic use, Enalapril therapeutic use, Hypertension drug therapy, Insulin metabolism, Nifedipine therapeutic use
- Abstract
It was previously demonstrated that metabolic syndrome in humans is associated with an impairment of insulin signalling in circulating mononuclear cells. At least in animal models of hypertension, angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) may correct alterations of insulin signalling in the skeletal muscle. In the first study, we investigated the effects of a 3-month treatment with an ARB with additional PPARγ agonist activity, telmisartan, or with a dihydropyridine calcium channel blocker, nifedipine, on insulin signalling in patients with mild-moderate essential hypertension. Insulin signalling was evaluated in mononuclear cells by isolating them through Ficoll-Paque density gradient centrifugation and protein analysis by Western Blot. An increased expression of mTOR and of phosphorylated (active) mTOR (p-mTOR) was observed in patients treated with telmisartan, but not in those treated with nifedipine, while both treatments increased the cellular expression of glucose transporter type 4 (GLUT-4). We also investigated the effects of antihypertensive treatment with two drug combinations on insulin signalling and oxidative stress. Twenty essential hypertensive patients were included in the study and treated for 4 weeks with lercanidipine. Then they were treated for 6 months with lercanidipine + enalapril or lercanidipine + hydrochlorothiazide. An increased expression of insulin receptor, GLUT-4 and an increased activation of p70S6K1 were observed during treatment with lercanidipine + enalapril but not with lercanidipine + hydrochlorothiazide. In conclusion, telmisartan and nifedipine are both effective in improving insulin signalling in human hypertension; however, telmisartan seems to have broader effects. The combination treatment lercanidipine + enalapril seems to be more effective than lercanidipine + hydrochlorothiazide in activating insulin signalling in human lympho-monocytes.
- Published
- 2014
- Full Text
- View/download PDF
9. Circulating endothelial progenitor cells, microvascular density and fibrosis in obesity before and after bariatric surgery.
- Author
-
De Ciuceis C, Rossini C, Porteri E, La Boria E, Corbellini C, Mittempergher F, Di Betta E, Petroboni B, Sarkar A, Agabiti-Rosei C, Casella C, Nascimbeni R, Rezzani R, Rodella LF, Bonomini F, Agabiti-Rosei E, and Rizzoni D
- Subjects
- Adult, Capillaries pathology, Female, Fibrosis blood, Fibrosis pathology, Fingers blood supply, Humans, Hypertension pathology, Hypertension surgery, Male, Microvessels pathology, Obesity pathology, Bariatric Surgery, Endothelial Cells pathology, Obesity blood, Obesity surgery, Stem Cells pathology
- Abstract
It is not known whether, in obesity, the capillary density or the number of circulating endothelial progenitor cells (EPCs) are reduced, or whether fibrosis of small vessels is also present. In addition, possible effects of weight reduction on these parameters have never been evaluated. Therefore, we investigated EPCs and capillary density in 25 patients with severe obesity, all submitted to bariatric surgery, and in 18 normotensive lean subjects and 12 hypertensive lean patients as controls. All patients underwent a biopsy of subcutaneous fat during bariatric surgery. In five patients, a second biopsy was obtained after consistent weight loss, about 1 year later, during a surgical intervention for abdominoplasty. EPCs and capillary density were reduced in obesity, and EPCs were significantly increased after weight reduction. Vascular collagen content was clearly increased in obese patients. No significant difference in vascular collagen was observed between normotensive obese patients and hypertensive obese patients. After pronounced weight reduction, collagen content was nearly normalized. No difference in stress-strain relation was observed among groups or before and after weight loss. In conclusion, our data suggest that microvascular rarefaction occurs in obesity. EPCs were significantly reduced in obese patients. Pronounced weight loss induced by bariatric surgery seems to induce a significant improvement of EPC number, but not of capillary rarefaction. A pronounced fibrosis of subcutaneous small resistance arteries is present in obese patients, regardless of the presence of increased blood pressure values. Consistent weight loss induced by bariatric surgery may induce an almost complete regression of microvascular fibrosis.
- Published
- 2013
- Full Text
- View/download PDF
10. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.
- Author
-
Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, Van Zwieten PA, Viigimaa M, and Zanchetti A
- Subjects
- Antihypertensive Agents administration & dosage, Blood Pressure drug effects, Humans, Hypertension diagnosis, Practice Guidelines as Topic, Hypertension drug therapy, Hypertension pathology
- Published
- 2009
- Full Text
- View/download PDF
11. Headache: Prevalence and relationship with office or ambulatory blood pressure in a general population sample (the Vobarno Study).
- Author
-
Muiesan ML, Padovani A, Salvetti M, Monteduro C, Poisa P, Bonzi B, Paini A, Cottini E, Agosti C, Castellano M, Rizzoni D, Vignolo A, and Agabiti-Rosei E
- Subjects
- Adult, Analgesics therapeutic use, Female, Headache complications, Headache drug therapy, Headache physiopathology, Humans, Hypertension complications, Hypertension drug therapy, Hypertension physiopathology, Italy, Male, Middle Aged, Predictive Value of Tests, Prevalence, Sex Factors, Blood Pressure, Blood Pressure Monitoring, Ambulatory methods, Headache epidemiology, Hypertension epidemiology
- Abstract
Unlabelled: The association of headache and arterial hypertension is still controversial, although headache is usually considered a symptom of hypertension. The aim of this study is to evaluate the prevalence of headache in a general population sample and the relationship with arterial hypertension, as diagnosed by office measurements and ambulatory monitoring of blood pressure (BP)., Patients and Methods: In the randomized sample of the Vobarno population, 301 subjects (126 males, 175 females, age range 35-50 years) underwent a structured standardized headache questionnaire, office and 24-h ambulatory BP monitoring., Results: Prevalence of lifetime headache and of migraine was greater in females than in males. Office and 24-h BP values did not differ between subjects without headache and subjects with headache. No differences in headache prevalence (58% vs 55%), migraine prevalence (32% vs 28%) and use of analgesic drugs in the presence of headache (82% vs 78%) were observed between hypertensive patients (93.5% newly diagnosed, 6.5% treated) and normotensive subjects., Conclusions: In a general population sample, hypertension (diagnosed by office and/or 24-h BP) is not associated with headache.
- Published
- 2006
- Full Text
- View/download PDF
12. Effects of olmesartan and enalapril at low or high doses on cardiac, renal and vascular interstitial matrix in spontaneously hypertensive rats.
- Author
-
Porteri E, Rodella L, Rizzoni D, Rezzani R, Paiardi S, Sleiman I, De Ciuceis C, Boari GE, Castellano M, Bianchi R, and Agabiti-Rosei E
- Subjects
- Animals, Blood Pressure drug effects, Dose-Response Relationship, Drug, Enalapril therapeutic use, Heart Rate drug effects, Hypertension complications, Imidazoles therapeutic use, Kidney cytology, Male, Muscle, Smooth, Vascular cytology, Myocytes, Cardiac cytology, Olmesartan Medoxomil, Rats, Rats, Inbred SHR, Rats, Inbred WKY, Tetrazoles therapeutic use, Enalapril pharmacology, Extracellular Matrix drug effects, Hypertension drug therapy, Imidazoles pharmacology, Tetrazoles pharmacology
- Abstract
We have evaluated the effects of different doses of an angiotensin-converting enzyme (ACE) inhibitor, enalapril (ENA) and of an angiotensin II type 1 receptor blocker olmesartan (OLM), on extracellular matrix of the heart, kidney, aorta and mesenteric artery of spontaneously hypertensive rats (SHR). Forty SHR and eight Wistar-Kyoto controls (WKY) were included in the study. Eight SHR were treated with high-dose OLM 15 mg/kg per day, eight with high-dose ENA 25 mg/kg per day, eight with low-dose OLM 1 mg/kg per day and eight with low-dose ENA (2 mg/kg per day). Eight SHR and eight WKY were kept untreated as controls. Treatment was from age 4 to 12 weeks. Systolic blood pressure (SBP) was measured non-invasively every week. The left ventricular weight to body weight (RLVM) was measured, and the cardiac, aortic and glomerular interstitial collagen content was evaluated using Sirius red staining and image analysis. Mesenteric small arteries were dissected and mounted on a micromyograph, and the media:lumen ratio (M/L) was calculated. Collagen subtypes were evaluated by polarized light microscopy. The SHR treated with high-dose OLM or ENA showed a normalization of SBP. The RLVM was significantly increased in untreated SHR compared with untreated WKY, whereas significantly lower values were observed in the groups of SHR treated with high-dose OLM or ENA. A significant increase in cardiac and glomerular collagen content was observed in untreated SHR. Both high- or low-dose OLM and ENA normalized collagen content in the heart and the kidney. Both high-dose OLM and high-dose ENA normalized M/L ratio; however, OLM proved to be more effective than ENA in normalizing collagen pattern. In fact, aortic collagen content was normalized by both high-dose and low-dose OLM, but only by high-dose ENA. In conclusion, both OLM and ENA were significantly and equally effective in the prevention of cardiac and renal damage in SHR, whereas OLM was more effective than ENA in terms of effects on vascular extracellular matrix.
- Published
- 2005
- Full Text
- View/download PDF
13. Role of ET(A) receptors in the vasoconstriction induced by endothelin-1 in subcutaneous small arteries of normotensive subjects and hypertensive patients.
- Author
-
Porteri E, Rizzoni D, Guelfi D, De CC, Castellano M, Bettoni G, Tiberio GA, Giulini SM, Sleiman I, and Agabiti-Rosei E
- Subjects
- Adipose Tissue blood supply, Arteries, Case-Control Studies, Dose-Response Relationship, Drug, Endothelin Receptor Antagonists, Endothelin-1 physiology, Female, Humans, Male, Middle Aged, Receptor, Endothelin A, Receptor, Endothelin B, Vasoconstriction physiology, Endothelin-1 pharmacology, Hypertension physiopathology, Receptors, Endothelin physiology, Vasoconstriction drug effects
- Abstract
Objective: The aim of our study was to investigate contractile responses to endothelin-1 in the presence or absence of selective blockers of ET(A) or ET(B) receptors in subcutaneous small resistance arteries of normotensive subjects and of patients with essential hypertension., Methods: Twenty-four subjects (eight normotensives aged 50 +/- 4 years, and 16 with essential hypertension aged 53 +/- 4 years) were included in the study. All subjects were submitted to a biopsy of the subcutaneous fat. Small resistance arteries (internal diameter 160-280 microm) were dissected and mounted on a micromyograph as a ring preparation (Mulvany's technique). The media-to-lumen ratio was calculated. A concentration-response curve to endothelin-1 was then performed in the presence or absence of FR 139317, (a selective blocker of ET(A) receptors) or of BQ 788, (a selective blocker of ET(B) receptors)., Results: The media-to-lumen ratio was lower in normotensives compared with those subjects with essential hypertension (0.08 +/- 0.02 vs. 0.12 +/- 0.05, p < 0.01). The vasoconstriction induced by endothelin-1 was greater in normotensives than in patients with essential hypertension. In normotensives, almost all the vasoconstriction induced by endothelin-1 was blocked by the addition of FR 139317, while in subjects with essential hypertension the effect was smaller. The selective blocker of ET(B) was devoid of effect in both groups., Conclusions: The vasoconstrictor effect of endothelin-1 in small resistance arteries of normotensive subjects and, in part, also in hypertensive patients is mediated by ET(A) receptors, while ET(B) receptors play a minor role, if any. It is, however, possible that a vasoconstrictor effect mediated by ET(B) receptors located on vascular smooth muscle cells may be masked by the simultaneous stimulation of endothelial ET(B) receptors which may induce a vasodilation mediated by nitric oxide.
- Published
- 2002
- Full Text
- View/download PDF
14. Hypertensive left ventricular hypertrophy: pathophysiological and clinical issues.
- Author
-
Agabiti-Rosei E and Muiesan ML
- Subjects
- Cardiovascular Diseases etiology, Cardiovascular Diseases prevention & control, Electrocardiography, Humans, Hypertension physiopathology, Hypertension complications, Hypertrophy, Left Ventricular complications, Hypertrophy, Left Ventricular diagnosis, Hypertrophy, Left Ventricular drug therapy, Hypertrophy, Left Ventricular etiology
- Published
- 2001
- Full Text
- View/download PDF
15. Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.
- Author
-
Agabiti-Rosei E, Zulli R, Muiesan ML, Salvetti M, Rizzoni D, Corbellini C, and Monteduro C
- Subjects
- Adult, Aged, Antihypertensive Agents administration & dosage, Antihypertensive Agents pharmacology, Blood Pressure drug effects, Calcium Channel Blockers administration & dosage, Calcium Channel Blockers pharmacology, Delayed-Action Preparations, Diuretics, Double-Blind Method, Female, Heart Rate drug effects, Heart Ventricles pathology, Humans, Hydrochlorothiazide therapeutic use, Hypertension complications, Hypertrophy, Left Ventricular etiology, Hypertrophy, Left Ventricular pathology, Male, Middle Aged, Nifedipine administration & dosage, Nifedipine pharmacology, Organ Size drug effects, Sodium Chloride Symporter Inhibitors therapeutic use, Vascular Resistance drug effects, Ventricular Function, Left drug effects, Ventricular Remodeling, Antihypertensive Agents therapeutic use, Calcium Channel Blockers therapeutic use, Hypertension drug therapy, Hypertrophy, Left Ventricular prevention & control, Myocardium pathology, Nifedipine therapeutic use
- Abstract
The aim of this study was to evaluate the effect of the calcium antagonist Nifedipine GITS in a double-blind, randomized comparison with the diuretic hydrochlorothiazide (HCTZ) on reduction of left ventricular (LV) mass and minimal vascular resistance in a group of essential hypertensives with left ventricular hypertrophy (LVH). The effects on blood pressure and on echocardiographic LV functional parameters were also analysed. After two months of randomized treatment with Nifedipine GITS or HCTZ, if diastolic blood pressure was > 90 mmHg, a combination of the two drugs was given and was continued for 24 weeks. M-mode, 2D-guided echocardiography was used to measure LV mass index (LVMI) according to the "Penn convention". Minimal vascular resistance was measured in the forearm, from arterial pressure and maximal blood flow, using a strain gauge plethysmography. All examinations were performed before and after 8 and 24 weeks of treatment. Changes in LVMI were analysed at 8 weeks and at 24 weeks in patients receiving monotherapy ("according to protocol" analysis), and also at the end of treatment in patients taking Nifedipine or HCTZ monotherapy or the combination of the two drugs ("intention to treat" analysis). Both Nifedipine and HCTZ significantly reduced systolic and diastolic blood pressure (p < 0.001), without any significant difference between the two drug treatments. Heart rate was not significantly modified by either treatment. A progressive decrease in LVMI was observed after 8 and 24 weeks of treatment with Nifedipine monotherapy (ANOVA, p = 0.03), while the decrease in LVMI during HCTZ treatment did not progress further at 24 weeks (ANOVA, p = 0.49). A significant reduction of minimal vascular resistance was observed in patients treated with Nifedipine GITS monotherapy (ANOVA, p = 0.001), but not in the HCTZ group (ANOVA, p = 0.06). Comparison of changes of forearm minimal vascular resistance, considering baseline values, could demonstrate a greater effect during Nifedipine monotherapy as compared to HCTZ monotherapy. In conclusion, in a group of hypertensive patients with LVH, treatment for 24 weeks with Nifedipine GITS alone or in combination with HCTZ induced a significant reduction in LVMI and of forearm vascular structural changes, as evaluated by minimal vascular resistance. The decrease of minimal vascular resistance was significantly greater in patients treated with Nifedipine monotherapy, as compared to those given HCTZ.
- Published
- 1998
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.